Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1984 Mar;16(3):145–150. doi: 10.1007/BF00205420

Inhibition of liver metastases in murine colon adenocarcinoma by liposomes containing human C-reactive protein or crude lymphokine

Prakash S Thombre 1, Sharad D Deodhar 1,✉
PMCID: PMC11039143  PMID: 6561065

Abstract

Previous studies from our laboratory have shown that liposomes containing LYNK or CRP inhibit lung metastases in mice bearing the malignant fibrosarcoma, T241. We have now extended these observations to the murine colon adenocarcinoma (MCA-38), which metastasizes to the liver. MCA-38 tumor cells (1×106) were implanted in the wall of the cecum by orthotopic transplantation. Three-hundred twenty-six mice bearing such tumors were divided into four treatment groups as follows: (1) no treatment (2) liposomes containing control medium (3) liposomes containing LYNK, and (4) liposomes containing CRP. Treatment was started from day 2, day 18, or 34 after tumor implantation and it was administered on 3 days per week. Each treatment, given parenterally, consisted of 4 μmol liposomes (PS-PC, 1:1) containing the appropriate agents. Mice receiving liposomes containing LYNK or CRP had significantly fewer and smaller liver metastases (25%–28%), than those in the two control groups (53%–54%). Also, a significantly better survival was noted in the two treated groups than in the two control groups. The most likely mechanism of tumor inhibition appears to be through macrophage activation. In the Winn tumor neutralization test, peritoneal macrophages harvested from normal mice 24 h after a single injection of liposomes (2.5 μmol) containing LYNK or CRP markedly inhibited tumor growth when a mixture of effector-target cells (40:1) was injected in the footpad. These studies further confirm the suggested role of CRP as an ‘immunomodulator’ or ‘biological response modifier’ in yet another tumor system.

Keywords: Liver Metastasis, Peritoneal Macrophage, Inhibit Tumor Growth, Response Modifier, Fibrosarcoma

Footnotes

Abbreviations used: LYNK, crude lymphokines; CRP, C-reactive protein; PC, phosphatidylcholine; PS, phosphatidylserine; PEC, peritoneal exudate cells; HBSS, Hank's Balanced Salt Solution; RPMI, Roswell Park Memorial Institute Con A, Concanavalin A; IgG, human gamma globulin; DMH, dimethylhydrazine

References

  • 1.Baldwin RW. Relevant animal models for tumor immunotherapy. Cancer Immunol Immunother. 1976;1:197. [Google Scholar]
  • 2.Barna B, Edinger M, Jacobs B, James K, Deodhar S. Effects of liposome-encapsulated mediators on macrophage function. Fed Proc. 1982;41:436. [Google Scholar]
  • 3.Barna BP, Gautam S, Roberts D, Edinger M, Deodhar SD. Antitumor activity of peritoneal exudate cells exposed to liposome-associated C-reactive protein. Fed Proc. 1983;42:680. [Google Scholar]
  • 4.Baum L, Glaviano R, James K, Gewurz H. The effects of anti-CRP on natural killer activity. Fed Proc. 1981;40:1045. [Google Scholar]
  • 5.Breedis LB, Woom C, Berwick ZP, Nowell P. Differential growth of metastatic tumors in liver and lung. Experiments with rabbit V2 carcinoma. Cancer Res. 1952;12:734. [PubMed] [Google Scholar]
  • 6.Claus D, Siegel J, Petras K, Osmand A, Gewurz H. Interactions of CRP with the first component of human complement. J Immunol. 1977;119:187. [PubMed] [Google Scholar]
  • 7.Corbett TH, Griswold DP, Robert BJ. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 1975;35:2434. [PubMed] [Google Scholar]
  • 8.Deodhar SD, Barna B, Edinger M, Chiang T. Inhibition of lung metastases by liposomal immunotherapy in a murine fibrosarcoma model. J Biol Resp Mod. 1982;1:27. [Google Scholar]
  • 9.Deodhar SD, James K, Chiang T, Edinger M, Barna B. Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein. Cancer Res. 1982;42:5084. [PubMed] [Google Scholar]
  • 10.Fidler IJ. Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science. 1980;208:1469. doi: 10.1126/science.7384789. [DOI] [PubMed] [Google Scholar]
  • 11.Fidler IJ, Kripke ML. Metastasis from pre-existing variant cells with a malignant tumor. Science. 1977;197:893. doi: 10.1126/science.887927. [DOI] [PubMed] [Google Scholar]
  • 12.Fidler IJ, Darnell JH, Budmen MB. In vitro activation of mouse macrophages by rat lymphocyte mediators. J Immunol. 1976;117:666. [PubMed] [Google Scholar]
  • 13.Fidler IJ, Sone S, Fogler WE, Barnes ZL. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci USA. 1981;78:1680. doi: 10.1073/pnas.78.3.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fidler IJ, Barnes Z, Fogler WE, Kirsh R, Bugelski P, Poste G. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res. 1982;42:496. [PubMed] [Google Scholar]
  • 15.Fletcher TC, Thomson AW, Baldo BA. Effect of lumpsucker (Cyclopterus lumpus L.) C-reactive protein on DNA synthesis in cultured murine and fish leukocytes. Comp Biochem Physiol. 1980;67:127. [Google Scholar]
  • 16.Goldrosen MH. Murine colon adenocarcinoma — Immunobiology of metastases. Cancer. 1980;45:1223. doi: 10.1002/1097-0142(19800315)45:5+<1223::aid-cncr2820451330>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  • 17.Hewitt HB. Animal tumor models and their relevance to human tumor immunology. J Biol Resp Mod. 1982;1:107. [PubMed] [Google Scholar]
  • 18.James K, Hansen B, Gewurz H. Binding of CRP to human lymphocytes. J Immunol. 1981;127:2539. [PubMed] [Google Scholar]
  • 19.James K, Hansen B, Gewurz H. Interaction of CRP with subsets of cells bearing Fc receptor. J Immunol. 1981;127:2546. [PubMed] [Google Scholar]
  • 20.Kindmark CO. Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria. Clin Exp Immunol. 1971;8:941. [PMC free article] [PubMed] [Google Scholar]
  • 21.Kindmark CO. In vitro binding of human C-reactive protein by some pathogenic bacteria and zymosan. Clin Exp Immunol. 1972;11:283. [PMC free article] [PubMed] [Google Scholar]
  • 22.Martin DS, Stolfi RL, Fugman RA. Animal models for tumor immunotherapy. Cancer Immunol Immunother. 1977;2:77. [Google Scholar]
  • 23.Mortensen R, Gewurz H. Effects of C-reactive protein on the lymphoid system. II. Inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes. J Immunol. 1976;116:1244. [PubMed] [Google Scholar]
  • 24.Pepys MB, Dash AC, Fletcher TC, Richardson N, Munn E, Feinstein A. Analogues in other mammals and in fish of human plasma proteins, CRP and amyloid P-component. Nature. 1978;273:168. doi: 10.1038/273168a0. [DOI] [PubMed] [Google Scholar]
  • 25.Robey FA, Liu TY. Limulin: A C-reactive protein from limulus polyhemus. J Biol Chem. 1981;256:969. [PubMed] [Google Scholar]
  • 26.Sone S, Fidler IJ. In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes. Cell Immunol. 1981;57:42. doi: 10.1016/0008-8749(81)90118-0. [DOI] [PubMed] [Google Scholar]
  • 27.Talmadge JE, Wolmann SR, Fidler IJ. Evidence for the clonal origin of spontaneous metastases. Science. 1982;217:361. doi: 10.1126/science.6953592. [DOI] [PubMed] [Google Scholar]
  • 28.Tan MH, Holyoke ED, Goldrosen MH. Murine adenocarcinomas: Methods for selective culture in vitro. (Brief communication) J Natl Cancer Inst. 1976;56:871. doi: 10.1093/jnci/56.4.871. [DOI] [PubMed] [Google Scholar]
  • 29.Volanakis JE, Clements W, Schrohenloher R. C-reactive protein purification by affinity chromatography and physical-chemical characterization. J Immunol Methods. 1978;23:285. [Google Scholar]
  • 30.Weisburger JH. Colon carcinogens: Their metabolism and mode of action. Cancer. 1971;28:60. doi: 10.1002/1097-0142(197107)28:1<60::aid-cncr2820280113>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  • 31.Winn JH. Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cell stimulated by tumor homografts. J Immunol. 1961;86:228. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES